This document contains a checklist for evaluating a prostate SBRT treatment plan. It lists patient details like name, diagnosis, risk factors, and Gleason score. It also includes imaging, dose prescription details, and whether coverage targets and organ at risk constraints were achieved or desired. Key parameters evaluated include coverage of the CTV and PTV for the prostate and nodes, as well as dose-volume constraints for the rectum, bladder, bowel, femurs, bulb of penis, and urethra.

1. DR KANHU CHARAN PATRO
PROSTATE SBRT PLAN EVALUATION CHECK LIST
I. NAME UMR
II. DIAGNOSIS AGE
III. RISK
IV. GLEASON SCORE
V. PSA AT DIAGNOSIS POST HT3M/6M
VI. IPSS SCORE AT DIAGNOSIS POST HT3M/6M
VII. IMAGING AT DIAGNOSIS MRI PSMA
PROSTATE
SEMINAL VESICLES
NODES
VIII. IMAGING AT POST HT 3M/6M
PROSTATE
SEMINAL VESICLES
NODES
IX. DOSE PRESCRIBED PTV PROSTATE
PTV NODE
X. COVERAGE INDEX
PRIME STUDY
TARGET PARAMETER DESIRED ACHIEVED
CTV PROSTATE D
98
98%
CTV NODE IF D
98
98%
PTV PROSTATE D
98
95%
PTV NODE IF D
98
95%
XI. OAR PRIME PACE
PARAMETER DESIRED ACHIEVED PARAMETER DESIRED ACHIEVED
N+ N-
1. RECTUM V
14
<50% <40% D
50%
18.1Gy
V
17.5
<40% <30% D
20%
29Gy
V
28
<15% <15% D
1cc
36Gy
V
31.5
<8% <8% -- --
V
35
<3% <3% -- --
2. BLADDER V
14
<40% <35% D
40%
18.1Gy
V
17.5
<27% <20% V
37Gy
10cc
V
28
<20% <10% -- --
V
35
<3% <3% -- --
3. BOWEL V28 80CC D5cc 18.1Gy
V28 80CC -- -- D1cc 30Gy
4. FEMORAL RT V14 <5% D5% 14.5Gy
5. FEMORAL LT V14 <5% D5% 14.5Gy
6. BULB -- -- -- -- D50% 29.5Gy
7. URETHRA
PROSTATIC
-- -- -- -- D50% 42Gy